EMBO Announces 52 New Members for 2013
News May 21, 2013
Forty-three of the researchers reside in Europe and neighboring countries and are accompanied by the election of nine Associate Members from Canada, China, India, Japan and the United States. The EMBO membership currently comprises around 1600 life scientists.
“Our members are the basis for the international reputation of our organisation,” EMBO Director Maria Leptin said. “We have been building our network of members for almost 50 years and the EMBO membership is the foundation for our future growth and achievements. I look forward to the fresh input and ideas that the new EMBO members will bring to the organisation.”
The most recent scientists to join the EMBO membership come from 15 different countries and include 16 female scientists.
EMBO Members make invaluable contributions to the organization by providing suggestions and feedback on the activities of EMBO. They serve on selection committees for EMBO programmes and mentor young scientists. Their input has helped to promote excellence in life sciences since 1964.
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE
Fight Against Cancer: Drug Combination Helps Kickstart the Immune SystemNews
Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.
The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.